Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.47B P/E - EPS this Y -3.90% Ern Qtrly Grth -80.80%
Income -1.29B Forward P/E 4.11 EPS next Y 1.20% 50D Avg Chg 9.00%
Sales 15.14B PEG 1.85 EPS past 5Y -7.31% 200D Avg Chg 16.00%
Dividend N/A Price/Book 1.31 EPS next 5Y 2.00% 52W High Chg -10.00%
Recommedations 2.90 Quick Ratio 0.52 Shares Outstanding 1.11B 52W Low Chg 52.00%
Insider Own 1.88% ROA 3.88% Shares Float 1.10B Beta 1.25
Inst Own 49.68% ROE -12.45% Shares Shorted/Prior 23.98M/30.81M Price 10.33
Gross Margin 47.90% Profit Margin -8.53% Avg. Volume 9,977,924 Target Price 9.60
Oper. Margin 18.89% Earnings Date - Volume 2,932,469 Change -0.53%
About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Teva Pharmaceutical Industries News
01/27/23 Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
01/26/23 Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
01/25/23 Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More
01/25/23 Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
01/24/23 Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
01/23/23 No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
01/23/23 Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
01/19/23 Teva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)
01/14/23 3 Dirt Cheap Stocks to Buy in January
01/12/23 Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
01/10/23 TEVA Shares Rise on Broad Support for Opioids Settlement
01/09/23 UPDATE 1-Teva says opioids settlement to move forward in U.S.
01/09/23 Teva says opioids settlement to move forward in U.S
01/09/23 Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
01/09/23 Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States
01/06/23 Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
01/04/23 Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy
01/03/23 Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
06:15 AM 2 "Safe" Stocks That Are Anything But
12/22/22 Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
TEVA Chatroom

User Image Breezy24K Posted - 2 hours ago

30 January Biotech Analyst [3] $EVOK $TEVA $EVOK Announced that a joint stipulation of dismissal has been filed in the GIMOTI patent infringement case in the United States District Court for the District of New Jersey. The filing of the stipulation arises from $TEVA and Teva Pharmaceuticals USA, Inc.'s conversion from a Paragraph IV certification to a Paragraph III certification. A paragraph III Abbreviated New Drug Application (ANDA) is not eligible for approval until the last expiration date of current and potential future orange book listed patents for the reference listed drug in conjunction with appropriate FDA review.

User Image kinderspiel Posted - 2 hours ago

#farfetch partnership deal with luxury fashion house richemont inside its gorgeous, candy-colored packaging, is as confident a deal as I’ve seen in recent years #FTCH has a social, luxuriously sophisticated millennial fashion lover of a protagonist who is easy to root for, elite villains who are easy to hate, & trajectory dispensed FTCH acquires 47.5% stake in ynap (yoox, net-a-porter) + 12 richemont brands, consolidates control of ecommerce distribution into ‘hard luxury’ game (cartier, van cleef & arpels, piaget & buccellatti) $NTDOY upcoming catalysts include q results & guidance changes (the grand opening of super nintendo world at universal studios hollywood, super mario bros movie, legend of zelda: tears of the kingdom) & increase production of the switch into fy24 $WYNN ↑ post $LVS upbeat macau reopening commentary on the company's q4 call $CPRX received notice that $TEVA submitted an anda filing to the FDA for generic firdapse, which ‘should not have come as a surprise’

User Image TheRipple Posted - 2 hours ago

$TEVA 10/30

User Image StockConsultant Posted - 16 hours ago

$TEVA Teva Pharmaceutical stock pullback with high trade quality , see https://stockconsultant.com/?TEVA

User Image macroaxis Posted - 1 day ago

$TEVA - Strong volume event (Chaikin AD Line) detected for Teva Pharma, downward reversal… https://www.macroaxis.com/stocks/Volume-Indicators/Chaikin-AD-Line/TEVA

User Image xxtramoney Posted - 1 day ago

$TEVA https://finance.yahoo.com/news/teva-pharmaceutical-industries-teva-great-144002311.html

User Image advancedlong Posted - 2 days ago

$TEVA https://twitter.com/nytimes/status/1619329475967127552?s=46&t=bj-cc3FjrPyVkfV4rIJY9Q

User Image Hopewisper Posted - 2 days ago

$TEVA

User Image DocDriz Posted - 2 days ago

$TEVA Opened PUT position. 2/3/23 expiration.

User Image TheDudeCAP Posted - 2 days ago

$TEVA Looking like rope-a-dope. Does this look familiar?...

User Image sleekoptions_twits Posted - 3 days ago

Peak profit for the last 6 expired option alerts for $TEVA 500.00| 250.00| 441.67| 78.05| -90.63| 400.00|

User Image Josephmrp1 Posted - 3 days ago

$TEVA What is the fuel behind this run up?

User Image NNJAWINLIVE Posted - 3 days ago

$TEVA going to move up hard from here

User Image EarningsInsider Posted - 3 days ago

Teva Pharmaceutical Industries Sees Short Interest Decrease from 31,470,000 shares to 25,020,000 shares. $TEVA https://www.marketbeat.com/s

User Image loudei Posted - 3 days ago

$TEVA I miss @Terrordome

User Image kinderspiel Posted - 3 days ago

momentum activity traded by institutions with options transaction volume 4.5x the average daily volume FTCH shows a prevailing real value of $17.2 per share. amazing things happen on farfetch.com things the richest 1% never seen in retail .. things we didn't know luxury sellers could do. talent was poached from fashion brands & media houses in the early years to help shape the brand. when the company crossed the unicorn mark of $1 billion valuation in 2015, they had a development team of more than 200, something no other fashion brand was doing. FTCH has partnerships with major fashion brands (Chanel), social-good platforms (Kiva), & innovative pilot programs like Second Life where they aggregate 2nd hand goods for luxury retailers & offer users a credit to spend $ZM sees limited upside in meetings growth $PLRX announcing data from its INTEGRIS-IPF Phase 2a trial $LCID ↑ after a buy rating $CPRX ↓ after being notified that $TEVA submitted an ANDA to the U.S. FDA for FIRDAPSE

User Image bosman0 Posted - 4 days ago

$TEVA time to move up to $11 before earnings and then a breakout, lets go!

User Image UltraAlgo Posted - 4 days ago

$TEVA Put-Call ratio by Volume => 0.26 expiration 2023-01-27. https://pbs.twimg.com/media/FnX1qNHWAAALP84.png

User Image CryptoAtlas Posted - 4 days ago

$STNE Wish I had bought more. STNE and $TEVA will be making it rain this year. Just got a big position in $PGY too.

User Image CryptoAtlas Posted - 4 days ago

$TEVA Ok. Let's resume the climb today.

User Image BuBleRunner Posted - 4 days ago

$TEVA bear trend!

User Image Nuclearrx Posted - 4 days ago

$TEVA junk junk junk

User Image tickeron Posted - 4 days ago

How to make the right investment? Compare $AMRX vs. $TEVA. #AmnealPharmaceuticals https://srnk.us/go/4348075

User Image bosman0 Posted - 4 days ago

$TEVA Bottom is in, loading up on June calls before earnings

User Image isa1 Posted - 4 days ago

$TEVA

User Image bassace Posted - 4 days ago

$TEVA

User Image shortablestocks Posted - 5 days ago

$TEVA is short sale restricted for 2023-01-25. https://www.shortablestocks.com/?TEVA

User Image BidaskBot Posted - 5 days ago

TevaPharmaceuticalIndustries $TEVA BidaskScore is Downgraded to Held https://bidaskclub.com/news/company/2023-01-24/TEVA

User Image Terrordome Posted - 5 days ago

$TEVA 🤣🤣🤣

User Image bassace Posted - 5 days ago

$TEVA Volume is non existent allowing the vampires known as market makers to bleed it down which has been their playbook for 5 years running.

Analyst Ratings
Piper Sandler Underweight Nov 23, 22
JP Morgan Underweight Nov 14, 22
BMO Capital Market Perform Nov 7, 22
B of A Securities Buy Aug 5, 22
Goldman Sachs Neutral Aug 2, 22
UBS Neutral Jun 14, 22
B of A Securities Neutral May 17, 22
Goldman Sachs Neutral May 12, 22
Piper Sandler Underweight May 4, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kalif Eliyahu Sharon EVP, Chief Financial.. EVP, Chief Financial Officer Aug 22 Sell 10.0666 55,500 558,696 9,376 08/24/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Jul 28 Sell 9.0365 58,163 525,590 2,974 07/29/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D May 17 Sell 8.2159 130,000 1,068,067 1,387 05/19/22
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 04 Sell 7.44 34,792 258,852 78,072 03/08/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Mar 04 Sell 7.42 10,897 80,856 165,381 03/08/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Mar 04 Sell 7.44 58,952 438,603 43,182 03/08/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 28 Sell 8.14 6,452 52,519 21,380 03/02/22
Shani Eli EVP,Global Marketing.. EVP,Global Marketing&Portfolio Feb 28 Sell 8.14 5,311 43,232 9,091 03/02/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 28 Sell 8.14 7,590 61,783 65,509 03/02/22
Drape Eric Executive VP Global.. Executive VP Global Operations Feb 28 Sell 8.14 9,797 79,748 45,830 03/02/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Feb 28 Sell 8.14 4,862 39,577 99,457 03/02/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Feb 28 Sell 8.14 20,598 167,668 20,280 03/02/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 08 Sell 9.06 6,110 55,357 9,402 02/10/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer May 13 Sell 10.22 37,884 387,174 2,974 05/13/21
Drape Eric Executive VP Global.. Executive VP Global Operations May 13 Sell 10.22 19,804 202,397 73,128 05/13/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 08 Sell 10.58 12,935 136,852 03/08/21
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 08 Sell 10.58 6,183 65,416 55,048 03/08/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Mar 08 Sell 10.57 6,012 63,547 77,976 03/08/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 04 Sell 10.88 1,400 15,232 03/04/21
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 17 Sell 11.12 2,098 23,330 103,294 02/17/21
O'Grady Brendan P. EVP, North America C.. EVP, North America Commercial Feb 11 Sell 12.69 20,694 262,607 78,146 02/11/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Feb 11 Sell 12.69 29,657 376,347 59,404 02/11/21
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Sep 10 Sell 8.98 333 2,990 10,765 09/10/20